Peritoneal carcinomatosis of colon cancer origin: Highest incidence in women and in patients with right-sided tumors

Journal of Surgical Oncology

Volumn 104, Issue 7, 2011, Pages 792-797

  Sjo, Ole Helmer ^a   Berg, Marianne ^b,c   Merok, Marianne Arstad ^a,b,d   Kolberg, Matthias ^b,c   Svindland, Aud ^a,d   Lothe, Ragnhild A ^b,c,d   Nesbakken, Arild ^a,d  

^a AKER UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

colon cancer; peritoneal carcinomatosis; TP53 mutation; tumor location

Indexed keywords

DNA; PROTEIN P53;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER LOCALIZATION; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CARCINOMATOUS PERITONITIS; CASE STUDY; COHORT ANALYSIS; COLON ADENOCARCINOMA; CONTROLLED STUDY; DNA ISOLATION; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PERITONEUM METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GENES, P53; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; NORWAY; PERITONEAL NEOPLASMS; PROSPECTIVE STUDIES; SEX DISTRIBUTION;

EID: 80255123505     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21959     Document Type: Article

References (21)

1. Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP,: Peritoneal carcinomatosis of colorectal origin: Incidence and current treatment strategies. Ann Surg 2006; 243: 212-222. (Pubitemid 43185440)
2. Confuorto G, Giuliano ME, Grimaldi A, Viviano C,: Peritoneal carcinomatosis from colorectal cancer: HIPEC? Surg Oncol 2007; 16: S149-S152.
3. Ceelen WP, Bracke ME,: Peritoneal minimal residual disease in colorectal cancer: Mechanisms, prevention, and treatment. Lancet Oncol 2009; 10: 72-79.
4. Jayne D,: Molecular biology of peritoneal carcinomatosis. In:, Celen WP, editor. Peritoneal carcinomatosis. A multidisciplinary approach. Gehnt, Belgium: Springer; 2006. pp. 21-31.
5. Lifante J, Glehen O, Cotte E, et al.: Natural history of peritoneal carcinomatosis from digestive origin. In:, Celen WP, editor. Peritoneal carcinomatosis. A multidisciplinary approach. Gehnt, Belgium: Springer; 2006. pp. 119-129.
6. Day DW, Morson BC,: The adenoma-carcinoma sequence. Major Probl Pathol 1978; 10: 58-71.
7. Fearon ER, Vogelstein B,: A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767.
8. Vogelstein B, Lane D, Levine AJ,: Surfing the p53 network. Nature 2000; 408: 307-310.
9. Borresen-Dale AL, Lothe RA, Meling GI, et al.: TP53 and long-term prognosis in colorectal cancer: Mutations in the L3 zinc-binding domain predict poor survival. Clin Cancer Res 1998; 4: 203-210. (Pubitemid 28062897)
10. Iacopetta B, Russo A, Bazan V, et al.: Functional categories of TP53 mutation in colorectal cancer: Results of an International Collaborative Study. Ann Oncol 2006; 17: 842-847.
11. Lothe RA, Peltomaki P, Meling GI, et al.: Genomic instability in colorectal cancer: Relationship to clinicopathological variables and family history. Cancer Res 1993; 53: 5849-5852. (Pubitemid 24006146)
12. Thorstensen L, Lind GE, Lovig T, et al.: Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability. Neoplasia 2005; 7: 99-108. (Pubitemid 40315987)
13. Petitjean A, Mathe E, Kato S, et al.: Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: Lessons from recent developments in the IARC TP53 database. Hum Mutat 2007; 28: 622-629. (Pubitemid 46744292)
14. Sadeghi B, Arvieux C, Glehen O, et al.: Peritoneal carcinomatosis from non-gynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study. Cancer 2000; 88: 358-363. (Pubitemid 30051820)
15. Glehen O, Gilly FN, Sugarbaker PH,: New perspectives in the management of colorectal cancer: What about peritoneal carcinomatosis? Scand J Surg 2003; 92: 178-179. (Pubitemid 36749752)
16. Sugarbaker PH,: Strategies for the prevention and treatment of peritoneal carcinomatosis from gastrointestinal cancer. Cancer Invest 2005; 23: 155-172. (Pubitemid 40463914)
17. Sugarbaker PH,: New responsibilities in the management of colorectal cancer with peritoneal seeding. Cancer Invest 2002; 20: 1118-1122. (Pubitemid 35315949)
18. Royal RE, Pingpank JF, Jr.:, Diagnosis and management of peritoneal carcinomatosis arising from adenocarcinoma of the colon and rectum. Semin Oncol 2008; 35: 183-191. (Pubitemid 351479211)
19. Statistical Yearbook 2009: Life expectancy. Oslo: Statistics Norway, 2009.
20. Russo A, Bazan V, Iacopetta B, et al.: The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: Influence of tumor site, type of mutation, and adjuvant treatment. J Clin Oncol 2005; 23: 7518-7528. (Pubitemid 46291815)
21. Hamelin R, Laurent-Puig P, Olschwang S, et al.: Association of p53 mutations with short survival in colorectal cancer. Gastroenterology 1994; 106: 42-48. (Pubitemid 24011863)